Synthetic Cannabinoid Activity Against Colorectal Cancer Cells
Abstract Introduction: Colorectal cancer (CRC) is a leading cause of cancer-related deaths worldwide, and new therapeutic strategies are still required. Here
synthetic
Low-Dose Cannabinoid Type 2 Receptor Agonist Attenuates Tolerance to Repeated Morphine Administration via Regulating μ-Opioid Receptor Expression in Walker 256 Tumor-Bearing Rats.
Authors: Zhang M, Wang K, Ma M, Tian S, Wei N, Wang G. Abstract BACKGROUND: Morphine is widely used in
Anti-Obesity Effect of the CB2 Receptor Agonist JWH-015 in Diet-Induced Obese Mice.
Authors: Verty AN, Stefanidis A, McAinch AJ, Hryciw DH, Oldfield B. Abstract The cannabinoid receptor 2 (CB2) is well known for
